Skip to main content
Black Health logo Black Health

Sickle Cell · Ohio

Sickle cell disease resources in Ohio

SCDAA chapter Medicaid: CRISPR covered NHLBI SCDIC state ~3,700 SCD patients

SCDAA chapter

SCDAA — Northwest Ohio (and Central Ohio chapter)

Visit chapter site 1-419-254-4883

Cincinnati Children's, Nationwide Children's (Columbus), and Rainbow Babies in Cleveland run Ohio's three largest pediatric SCD programs; Ohio State Wexner Medical Center runs the adult clinic in Columbus and is an NHLBI-SCDIC member. Ohio participates in the CDC Sickle Cell Data Collection program, and Ohio Medicaid published written CRISPR gene-therapy coverage in 2024.

Roughly 3,700 people in Ohio are estimated to live with sickle cell disease; the figure comes from the CDC's Sickle Cell Data Collection program in participating states and from NHLBI modeling elsewhere. Ohio began universal newborn screening for sickle cell disease in 1989 — every baby born in the state is now screened at birth, which lets families start twice-daily penicillin prophylaxis by two months old and dramatically reduces childhood SCD mortality. For confirmatory testing and hematology follow-up after a positive screen, ask your pediatrician for a referral to the closest comprehensive sickle cell center listed on this page.

Ohio Medicaid covers hydroxyurea — the cornerstone disease-modifying therapy for SCD. Ohio Medicaid published written coverage policy for Casgevy (exa-cel) and Lyfgenia (lovo-cel) in 2024. As of 2026, only roughly 45 comprehensive centers nationally are authorized to administer Casgevy (exa-cel), and fewer still are authorized for Lyfgenia (lovo-cel). Coverage status alone doesn't guarantee access — patients must be at least 12 years old with recurrent vaso-occlusive crises, enrolled at an authorized center, and cleared through the center's multi-step stem-cell-collection and conditioning protocol.

Community support in Ohio runs through SCDAA — Northwest Ohio (and Central Ohio chapter). SCDAA chapters coordinate annual Sickle Cell Awareness events, patient education, and advocacy — most keep a current list of pediatric and adult comprehensive clinics in the state and can help patients navigate insurance pre-authorization for disease-modifying therapies.

Ohio at a glance

Newborn screening start
1989
Estimated SCD patients in state
~3,700
Medicaid: hydroxyurea
Covered
Medicaid: CRISPR gene therapy
Covered (written policy published)

Comprehensive care centers in Ohio

Cincinnati Children's Sickle Cell Center

Cincinnati, OH

Pediatric Transition

Nationwide Children's Sickle Cell Program

Columbus, OH

Pediatric Transition

Ohio State Adult Sickle Cell Program

Columbus, OH

Adult Transition CRISPR

UH Rainbow Babies & Children's Sickle Cell Program

Cleveland, OH

Pediatric Transition

For Black families

Roughly 1 in every 365 Black infants born in the United States inherits sickle cell disease, and roughly 1 in 13 carries the sickle cell trait — the highest carrier frequency of any population group in the country. Because newborn screening is universal, nearly every Black family in Ohio whose baby has SCD receives the diagnosis before they leave the hospital — which is exactly why timely follow-up with a comprehensive center matters more than the diagnosis itself.

The hardest periods in the SCD lifespan are the transition from pediatric to adult care (roughly ages 18-25, when preventable mortality peaks) and emergency-department visits for vaso-occlusive crises, where published research has consistently documented longer time-to-analgesia and higher suspicion of drug-seeking behavior for Black SCD patients than for white patients with comparable pain. Transition programs, pain plans, and hematologist letters addressed to ED staff reduce both. Every comprehensive center listed on this page supplies those materials on request.

Where to get help in Ohio

  • SCDAA — Northwest Ohio (and Central Ohio chapter): https://sicklecellohio.org/ · 1-419-254-4883. The state's primary community organization for SCD advocacy, peer support, and family education.
  • Hematology-oncology providers in Ohio: /providers/?state=OH&specialty=hematology-oncology. Filter our directory to hematology-oncology specialists.
  • Federally Qualified Health Centers in Ohio: /clinics/oh/. FQHCs accept Medicaid, charge on a sliding scale, and are the practical first stop when you need a primary-care home that will coordinate SCD specialty referrals.
  • Ohio Medicaid: /medicaid/ohio/ covers eligibility, how to apply, and our ohio tracker for 12-month postpartum extension + doula coverage — relevant to pregnant people carrying sickle cell trait or SCD.
  • CDC Sickle Cell Data Collection program: cdc.gov/ncbddd/hemoglobinopathies/scdc publishes claims-based SCD prevalence for participating states.
  • National SCDAA Connect line: 1-800-421-8453. Routes callers to local chapter resources and hospital social-work teams experienced with SCD.

More on Ohio

Hematology providers

Hematology-oncology in Ohio

Filter the provider directory to SCD-treating hematologists.

FQHCs

Federally Qualified Health Centers

Sliding-scale clinics accepting Medicaid.

Ohio Medicaid

Medicaid coverage in Ohio

Eligibility, postpartum, doula coverage.

References

  • NHLBI, "Evidence-Based Management of Sickle Cell Disease" (2014 expert panel report): nhlbi.nih.gov.
  • American Society of Hematology 2020 SCD Clinical Practice Guidelines: hematology.org.
  • CDC Sickle Cell Data Collection program: cdc.gov/ncbddd/hemoglobinopathies/scdc.
  • Baby's First Test, state-by-state newborn screening panel: babysfirsttest.org.
  • SCDAA — Northwest Ohio (and Central Ohio chapter): https://sicklecellohio.org/.
  • FDA approvals, December 2023: Casgevy (exagamglogene autotemcel, Vertex) + Lyfgenia (lovotibeglogene autotemcel, bluebird bio), CRISPR-based gene therapies for severe SCD.

Data refreshed: